The ability of the NMDA receptor antagonist, MK-80 I, to protect myelinated axons after focal cerebral isch emia has been examined. Amyloid precursor protein (APP) immunocytochemistry was used to assess the anatomic extent of axonal injury, and conventional histopathology was used to assess the volume of ischemic damage to neuronal perikarya.
Myelinated axons are essential for the normal func tioning of the brain. The function and ultimately the structural integrity of white matter are, like gray matter, dependent on a continuous supply of energy. White mat ter has long been considered to be less vulnerable than gray matter to ischemia (Marcoux et aI., 1982) . How ever, recent evidence using a variety of markers targeting different structures within axons has demonstrated the acute vulnerability of axons to cerebral ischemia in vivo (Dewar and Dawson, 1997; Yam et aI., 1998a) , and the mechanisms of axonal injury and strategies for its pro tection appear to differ from those in neuronal cell bodies in gray matter. Waxman et aI., using an in vitro model of isolated optic nerves, have shown that myelinated axons are susceptible to anoxia in the absence of their perikarya and that functional and structural impairment occurs within the axon itself, and not only as a consequence of impaired perikaryal function (Waxman et aI., 1991 (Waxman et aI., , 1992 . Although Stys (1996 Stys ( , 1998 has proposed that at least qualitatively the mechanisms described using the in vitro optic nerve model are pertinent to in vivo condi tions, axonal injury in vivo after focal cerebral ischemia has been the subject of limited investigation.
Quantitative immunocytochemical methods have been developed to define axonal pathology after focal cerebral ischemia (Yam et aI., 1998b) . Amyloid precursor protein (APP) is transported by fast anterograde axonal transport (Koo et aI., 1990) . After a variety of cerebral insults, APP accumulates in bulb like swellings at the point of transport failure, and these are thought to be a precursor of axotomy (Kawarabayashi et aI., 199 1; Otsuka et aI. , 1991; Nakamura et aI., 1992; Povlishock, 1992; Ste phenson et aI., 1992; Kalaria et aI., 1993) . APP immu nocytochemistry has been used widely to detect axonal injury after head injury and ischemic insults in humans and animals because of its high sensitivity (Stephenson et aI., 1992; Kalaria et aI., 1993; Blumbergs et aI., 1994; Sherriff et aI., 1994a; Suenaga et aI., 1994; Gentleman et aI., 1995; McKenzie et aI., 1996) . A topographic relation and a statistical association have been demonstrated in the rat between axonal APP accumulation and neuronal necrosis after middle cerebral artery (MCA) occlusion in the absence of pharmacologic intervention (Yam et aI., 1997) .
Many drugs targeted at N-methyl-D-aspartate (NMDA) receptors have advanced to clinical trials in stroke and head injury based on their proven ability to reduce gray matter damage in animal models of focal cerebral isch emia (McCulloch, 1992) . The outcome to date of the clinical trials of NMDA receptors has been disappoint ing, with no proof of improved functional outcome in patients (Dyker and Lees, 1998) . Although the failure to translate preclinical insight into therapy is multifactorial, we have proposed that the inability of NMDA receptor antagonists to improve functional outcome in humans may relate to their failure to protect oligodendrocytes and axons in white matter (Dewar et aI., 1999b) . White matter contains negligible levels of NMDA receptors (Jones and Baughman, 1991) , and NMDA antagonists are not protective in the rat optic nerve model (Stys, 1998) .
In the present study, we sought first to establish in the cat whether the anatomic extent of axonal injury in white matter (assessed by APP accumulation) was related to the volume of neuronal necrosis in gray matter (assessed by conventional histopathology). Second, we examined whether pretreatment with the NMDA antagonist, MK-801, altered the relati ve amounts of white matter and gray matter injury, assessed using the same techniques. The investigations were conducted in the cat because of its similar proportion of white matter to humans and because of the compelling evidence that MK-801 re duces ischemic damage to neuronal perikarya in gray matter in this species (Ozyurt et aI., 1988; Park et aI., 1988a; Uematsu et aI., 1991; Dezsie et aI., 1992) .
METHODS
Sixteen adult cats were anesthetized and MeA occlusion was performed. The cats were anesthetized initially with alphaxa lone/alphadolone (9 mg/kg given intravenously), intubated, and connected to a positive-pressure ventilator delivering nitrous oxide and oxygen in an open circuit. Polyethylene catheters were inserted into both femoral veins and one femoral artery for the administration of drugs and the continuous monitoring of arterial blood pressure and blood gases. Anesthesia was maintained throughout the course of the investigation with in travenous chloralose (60 mg/kg), supplemented as necessary to prevent the return of the corneal reflex. Throughout the experi mental period, the animals were maintained normotensive (mean arterial blood pressure greater than 80 mm Hg) and normocapnic (P"c02 close to 32 mm Hg) by adjusting the stroke volume of the respirator. Metabolic acidosis was corrected by administration of 8.4% sodium bicarbonate. Samples of arterial blood were taken frequently to determine the respiratory status using a direct-reading electrode system. The cats were main tained normothermic by means of a heating blanket with feed back control using a rectal thermometer.
The left MeA was occluded using a transorbital approach.
The head of the cat was placed in a stereotactic frame. With microsurgical techniques, the left orbit was exenterated and the optic foramen and optic fissure were enlarged with a dental drill to expose the dura mater overlying the MeA close to its origin. With the aid of an operating microscope, the dura was incised and the MeA exposed. The trunk of the MeA and all visible branches of the lenticulostriate arteries were coagulated with bipolar diathermy and divided with microscissors. After MeA occlusion, anesthesia was maintained for six hours, and physiologic parameters were monitored ( Table I ).
The cats were randomly divided into a vehicle-treated con trol group (n = 10) and a drug-treated group (n = 6). The drug-treated group received an intravenous bolus of MK-80 I (0.5 mg/kg) by intravenous injection 15 minutes before MeA occlusion; then, after completion of the bolus injection, MK-801 was infused at 0.14 mg/kg per hour (0.15 mLimin) for the duration of the experiment. The bolus and infusion concentra tions were selected to achieve a steady-state target plasma con centration of 300 nmollL, a dosing regimen based on the plasma half life of MK-80 I in this species (Ozyurt et aI., 1988 and their unpublished observations), knowledge of loading dose requirements (Mayer aI., 1975) , and definitions of the Data are presented as mean ± SO. Vehicle. n = 10 : MK-801, n = 6. MABP. mean arterial blood pressure .
plasma concentrations of MK-801 required for neuroprotection (Gill et aI., 1991) . The vehicle-treated control group of 10 cats received a l-mL intravenous injection of saline 15 minutes before MCA occlusion, followed by an intravenous saline in fusion at a rate of 0.15 mUmin for the duration of the experi ment.
Six hours after MCA occlusion, the cats were killed by trans cardiac perfusion fixation with 40% formaldehyde, glacial ace tic acid, and methanol (FAM) in a ratio of I: I :8. Briefly, the cat was placed in a supine position and given heparin. A thoracot omy was performed and a cannula introduced into the ascend ing aorta through the left ventricle. Physiologic saline was in fused at a pressure equivalent to mean arterial pressure until blood was removed from the body. This was followed imme diately by 1.5 L of FAM fixative at the same pressure. After perfusion, the cats were decapitated and the head was stored in fixative at 4°C for at least 12 hours; the brain was then removed and immersed in FAM for a further 24 hours before transfer to Morphologic characteristics of early neuronal necrosis (micro vacuolation, shrinkage, triangulation, and hyperchromasia of the cell body and nucleus) (Brierley and Graham, 1984) were charted on the diagrams drawn to scale and formed the basis of quantitative assessment of ischemic brain damage in a manner analogous to that previously described for the rat (Osborne et aI., 1987) . The area of ischemic necrosis in the cerebral hemi sphere, cerebral cortex, and caudate nucleus was determined from the diagrams at each of the 16 coronal planes. The vol umes of ischemic neuronal necrosis were calculated from the areas of damage at the different coronal planes and their ante rior-posterior coordinates.
Sections adjacent to those used for mapping areas of neuro nal necrosis were prepared for immunocytochemistry so that the amount of APP immunoreactivity could be quantified at the same coronal levels. Sections were mounted on slides coated with polY-L-lysine and dried at 37°C overnight. To remove the wax, the sections were placed in Histoclear (Natural Diagnos tics, Atlanta, GA, U.S.A.). The sections were dehydrated by placing them in absolute alcohol for 2 minutes, and they were then rinsed in methanol. They were left in methanol and hy drogen peroxide solution (0.5%) for 30 minutes. To enhance APP immunoreactivity, the sections were microwaved (Sherriff et ai., 1994b) in citrate buffer (pH 6) for 5 minutes, reexamined to ensure they were still covered with buffer, microwaved for a further 5 minutes, and then allowed to cool for 20 minutes. The sections were rinsed in tap water and phosphate-buffered saline The washing procedure with PBS was repeated, and then the sections were allowed to develop in 3,3' -diamino benzidine solution (Sigma, Poole, U.K.) for 8 to 10 minutes.
Finally, the sections were rinsed with water, dehydrated, cleared, and mounted in DPX mountant (Lamb, London, U.K.).
Because diaminobenzidine was used as the chromagen in the immunocytochemistry, the increase in APP immunoreactivity in the white matter viewed microscopically stained intensely brown (Fig. I) . Slides stained for APP from 16 coronal sections from each animal, at the defined coronal planes, were placed on a light box, and the image was captured using an 8-bit standard CCD video camera and transferred to an MCID-M4 image analyzer. The complete coronal section could then be viewed on a monitor and digitized, and the image was printed using a laser printer. The increased APP immunoreactivity was visible on the images (see Fig. I A) . The sections were also viewed using a conventional light microscope at x2.5 magnification.
Any increased APP immunoreactivity visible on the slides but not visible on the scanned images was transcribed onto the image. This procedure was repeated for each animal at each coronal level so that the region of increased APP immunore activity could be established at each coronal level for each animal in both groups.
For quantitative analysis of the APP immunoreactivity, we analyzed the images from 16 coronal sections, for each animal in both groups, showing the increased APP immunoreactivity.
A transparent counting grid, arranged in a regular square array, was randomly placed over each image, and the number of points overlying the area of increased APP immunoreactivity was counted. The total APP score for each animal was the sum of the points on target for all 16 coronal levels.
The intrarater variability and interrater reliability were as sessed on mUltiple randomly selected samples of images from the two cat populations and comparing the two sets of results.
Using the counting grid for the quantitative method of APP analysis, the intrarater correlation (r = 0.99) and the interrater correlation (r = 0.96) was excellent.
Our hypothesis was that MK-801 would fail to reduce the hemispheric APP score but would alter the relation with the volume of neuronal necrosis. To test this hypothesis, the hemi spheric APP scores in both groups were compared using Stu dent's t-test. The relation between the hemispheric APP score and the volume of neuronal necrosis was described by linear regression analysis (Pearson's). The slopes of the regression analysis for the vehicle and treatment groups were compared, as was the ratio of the hemispheric APP score and the volume of neuronal necrosis in individual animals between the two treatment groups using Student's t-test. To avoid the statistical issue of dimensionality, no other analyses were performed on the subcomponents of these data sets (e.g., APP scores in in dividual coronal planes, areas of neuronal necrosis, volumes of neuronal necrosis in different regions), which are reported for descriptive purposes. Data are presented as mean ± standard deviation.
RESULTS

Histopathology and APP immunocytochemistry
All brains were judged to be well perfusion-fixed, as evidenced by good neuronal morphology, the absence of (A) Digitized image of an APP-immunostained section at the level of the caudate nucleus in a vehicle-treated cat. A band of intense APP staining in the white matter surrounding the caudate nucleus is visible to the naked eye (white arrows). (8) APP-positive axonal swellings and bulbs in white matter viewed by light microscopy that were plotted onto the digitized images. The total area encompassing APP stained axonal swellings was determined using a point counting grid. (C) Neuronal perikarya (black arrows) in the cerebral cortex showing the morphologic characteristics of early necrosis were clearly evident in a hematoxylin and eosin-stained section. The boundary between these cells and those with a normal histologic appearance delineated the area of gray matter damage that was transcribed onto scale diagrams for quantitative assessment. Scale bars in 8 and C = 50 �m. intravascular blood, and the lack of cytoplasmic artifacts (Brown and Brierley, 1968) . Ischemic damage was ob served only within the territory of the occluded MCA (i.e., the dorsolateral cortex and the neostriatum). These areas showed the morphologic characteristics of early neuronal necrosis (Brierley and Graham, 1984) : neuronal perikarya with shrinkage and triangulation of the nucleus and cytoplasm and increased basophilia of cytoplasm (see Fig. lC ). In the hemisphere ipsilateral to the oc cluded MCA, circumscribed zones of intense APP im munoreactivity were observed in swollen or bulbous axons in subcortical white matter (see Fig. IB ). These zones of axons with increased APP immunoreactivity were particularly prominent in the ventral and lateral aspects of white matter and in white matter immediately adjacent to the caudate nucleus (see Fig. IA ). The his tologic appearance and anatomic location of the axons with increased APP immunoreactivity were similar in animals treated with vehicle and MK-801.
MK-801 and axonal injury
MK-80l failed to reduce significantly the total APP score summated from the 16 coronal levels examined (Fig. 2) . The total APP score (summated from individual scores in 16 planes) was 253 ± 65 for the vehicle-treated group and 322 ± 52 for the MK-80l group (see Fig. 2B ). The APP scores for each of the 16 planes were similar in vehicle-treated animals (Fig. 3) . Although MK-801 did not significantly alter the index of axonal injury (i.e., the APP score) MK-801 did alter significantly the rela tion between axonal injury and the volume of neuronal necrosis (Fig. 4) . In vehicle-treated animals, there was a significant association (r = 0.69, P < 0.03) between the hemispheric APP score and the volume of neuronal necrosis. MK-80 1 treatment altered significantly (P < 0.02) the slope of the association from 43 ± 16 x 10-3 in vehicle-treated animals to 6 ± 15 x 10-3 in MK-80 1 animals (see Fig. 4 ). The alteration in the relation be tween axonal injury and necrosis of neuronal perikarya was also reflected by an increase in the ratio of hemi spheric APP score and volume of neuronal necrosis from 0.17 ± 0.07 in the vehicle group to 0.32 ± 0.16 in the MK-801 group (P < 0.02) (see Fig. 2C ). There were no significant differences in any of the key physiologic variables between the vehicle-treated and MK-801 groups (see Table 1 ). 
Cortical Neuronal Necrosis
DISCUSSION
Quantitative accumulation of APP has been used pre viously to assess axonal injury in the rat after focal isch emia (Yam et aI., 1998b) . The present approach in the cat has several major advantages for assessing the ability of drugs to alter ischemic damage to myelinated axons. The use of a species (cat rather than rat) with a large gyrencephalic brain more closely reflects the cerebral anatomy of humans. In the cat, the proportionately larger volume of white matter compared with the rat allows easier assessment of protective effects in white matter after The mechanisms of cellular injury in white matter are less well understood than those in gray matter. However, myelinated fiber tracts, both in vitro and in vivo, are vulnerable to anoxic or ischemic injury, independent of perikaryal damage. Isolated optic nerves display struc tural damage in response to relatively short periods of anoxia (Stys, 1998; Waxman et aI., 1992) , as do myelin ated tracts in vivo in response to short periods of focal ischemia (Dewar and Dawson, 1997; Yam et aI., 1998a) .
In both experimental situations, axonal damage is asso ciated with derangements of cytoskeletal structure in volving both microtubule and neurofilament proteins.
Cytoskeletal breakdown at the point of ischemic injury is presumed to precede the accumulation of transported proteins such as APP (Stephenson et aI., 1992; Yam et aI., 1997 Yam et aI., , 1998a Dietrich et aI., 1998) . provides an assessment of the axons that may benefit from therapeutic intervention such as early reperfusion (Valeriani et aI., 2000) .
The temporal evolution of ischemic damage to neuro nal perikarya, and its reversibility, has been the subject of intensive investigation (Jones et aI., 1981) . It remains to be established whether the temporal evolution of axo nal injury parallels that of neuronal perikarya in relation to both the duration and severity of the ischemic insult. It is interesting that the APP scores in the MK-801 group were modestly increased compared with the controls; this may be due to rescue by the drug of neuronal peri karya that could maintain protein transport to the point of damage in their axons.
Although both components of the functional unit com prising the axon and its oligodendrocytes (Petito, (Ozyurt et aI., 1988; Park et aI., 1988a Park et aI., , 1988b (Li and Stys, 2000) . Oligodendrocytes in vitro and in vivo are insensitive to NMDA (McDonald et aI., 1998; Sanchez-Gomez and Matute, 1999) . MK-801 failed to reduce the extent of ischemic pathology in oligodendro cytes after MCA occlusion in the rat (Irving et aI., 1997) .
The reported success of NMDA antagonists in the pro tection of gray matter has permitted the progression of drugs to clinical trials in humans (Small and Buchan, 1997; Bullock, 1998) . The results of the phase III trials have generally been disappointing. Some of the trials have been stopped prematurely when interim analysis has raised concerns about the risk-benefit ratio, and oth ers have been stopped when no difference was found between active treatment and placebo (Muir and Lees, 1995) . cause of the vegetative state and severe disability after a head injury (Adams et aI., 1989) . However, the protec tion of myelinated fiber tracts has hitherto been largely neglected in preclinical investigations of drug action.
The use of agents targeted toward the protection of gray matter alone, such as MK-801, may be irrelevant to the preservation of brain function after a stroke or head in jury. The success of future strategies will depend on the development of either single agents or combination therapy targeted at the protection of both gray and white matter. Brain protection, rather than neuroprotection, may be the key to future success and should be the goal of antiischemic drug development.
